Quantcast
Viewing all articles
Browse latest Browse all 3411

Exclusive: Anti-aging mRNA therapy biotech acquires Harvard startup’s microvesicle delivery tech

Turn Biotechnologies, a startup developing mRNA therapies to wind back the clock on aging cells has acquired an experimental drug delivery technology from Harvard University and Vesigen Therapeutics, the company exclusively told Endpoints News. ...

Viewing all articles
Browse latest Browse all 3411

Trending Articles